[260 Pages Report] The global vascular access catheters market is estimated to achieve the valuation of US$ 3.0 Bn by end of 2022 and is expected to expand at a 5.7% CAGR over the forecast period (2022-2032). As of 2021, the non-antimicrobial segment has led the global vascular access catheters market with total estimation of US$ 2.2 Bn.
Market Outlook:
| Data | Market Insight |
|---|---|
| Estimated market Value 2022 | US$ 3.0 billion |
| Estimated market Value 2032 | US$ 5.3 billion |
| CAGR of 2022-2032 | 5.7 % |
| Market share of Top 5 countries | 57.0 % |
| Key Market players | AngioDynamics, C.R. Bard, Teleflex Incorporated, Kimal, B. Braun Melsungen AG, Vygon (UK) Ltd., Fresenius Kabi AG, Becton, Dickinson and Company, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Incorporated, Medical Components, Inc., Medtronic PLC., Terumo Medical Corporation, NIPRO Medical Corporation, Angiodynamics, Edwards Lifesciences Corporation. |
A vascular access catheter, also known as central line catheter, is a long, thin, flexible tube used to draw blood and body fluids from vein, including intravenous fluids, drugs, or blood transfusions. Central access catheters are used to for administering medicines, fluids, nutrients, blood and blood products. Also, these catheters are used for measuring central venous pressure (CVP), haemodialysis and chemotherapy over a long period of time.
Dialysis catheters are categorized into three segments mainly, acute haemodialysis catheter, chronic haemodialysis catheter and peritoneal dialysis catheters. A dialysis catheter is mainly utilized for exchanging blood to and from a haemodialysis machine and a patient. The dialysis catheter contains two lumens: venous and arterial. Other products include peripherally inserted central catheter (PICC) and implantable port. An implantable port is implanted or placed below the skin during surgical procedures. Ports can be used for providing intravenous drugs, fluids, food, or collecting blood samples. Central venous catheters (CVC) considered in the report falls under tunnelled and non-tunnelled product category.
Tunnelled catheters are inserted subcutaneously from the site of the insertion. The catheter and its attachments are underneath the skin. The risk of infection is lower due to subcutaneous tunnelling to distal exit site. Whereas non-tunnelled catheters are mostly inserted through subclavian vein or internal jugular vein. The insertion method is percutaneous venepuncture.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Vascular access catheters market has achieved the value of US$ 2.9 Bn in 2021, and is expected to expand at 5.7 % CAGR in terms of revenue over the forecast period (2022-2032). The vascular access catheters market has grown over a CAGR of 4.9% in the historic period from 2012-2021.
Growth of the global vascular access catheters market is mainly driven by rising adoption and growing demand for antimicrobial coated catheters, coupled with socio-economic factors such as increasing disease incidences due to growing ageing population. Increasing cases of cancer and chronic kidney disease is a major factor globally.
Further increasing the usage of new and advanced catheters in the developed regions, increase in prevalence of end stage renal diseases and rising numbers of vascular access surgeries are the trends expanding the global vascular access catheters market. Other prominent growth drivers are product innovations and increasing rates of hospitalisations.
Product category, insertion procedure, indication and the age of the patient are set to define the reimbursement landscape for vascular access catheters. Catheter manufacturers are expected to invest more on product design and quality to minimize the impact on patient safety.
Increasing cases of blood transfusions, growing demands of patients for central venous access, rise in the numbers of lifestyle related disorders and rising demands for technologically advanced vascular access devices are promising factors to propel the market in the forecast period.
Aforementioned factors are expected market drivers and anticipated to expand the market during the forecast period.
Implementation of tip location devices has improved the accuracy and efficiency of PICC and CVC insertion by helping physicians to position the PICC and CVC tip in proximity to the cardio arterial and large vein junction.
Increasing demand for central venous catheters, favorable support from government bodies in terms of reimbursement and commercialization of novel interventional solutions are major factors boosting collaborations and partnership agreements between manufacturers.
Companies in the central access devices market are making major investments in order to introduce innovative central venous catheter to capitalize on lucrative opportunities in the vascular access catheters market. Also, companies are working on key related issues such as prevention of thrombus formation and infection by introducing catheters with antimicrobial coatings.
The above mentioned factors are great prospects for manufacturers to raise the adoption rate of their products to create a strong consumer base and boost up the vascular access catheters market in forecast years.
Principal Consultant
High costs of antimicrobial coated catheters adversely affects its adoption in the consumers, the average cost of these catheters is three-four times more than the standard catheters. Thus, high cost of antimicrobial catheters is expected to hamper the growth of vascular access catheters market in the forecast period.
Significant risks and complications are associated with central venous catheterization procedures which can lead to mechanical complications such as bleeding, damage to blood vessel, arterial puncture, hematoma, and pneumothorax.
Infectious complications such as infection at the insertion site of the catheter, contamination of the catheter and haematogenous seeding of the catheter etc., ultimately results in low preference for the catheterization procedures in the patients, which can probably hinder the growth of vascular access catheters market in the coming times.
Catheter related blood stream infections with high costs of these devices is a major factor restraining growth of the market over the forecast period. Alongside, these devices causing infections, other concern is lack of education and training, new products coming in the market require proper training for their safe use, which is not only expensive but time consuming.
The above mentioned factors are probable constraints for the expansion of vascular access catheters market in the forecast period.
The U.S. has dominated the North American vascular access catheters market in 2021 with the regional revenue share of nearly 86% and is expected to grow over a CAGR of 6.4 % during the forecast period.
Over the time, the U.S. vascular access catheters market has tended to shift towards less expensive catheter devices with lower rate of failures. The midlines and extended dwell catheters have emerged as great alternatives for the PICC catheters, having longer dwell time with less invasion at lower cost than the latter one and it is expected that these devices will propel the U.S. market in the future.
As of 2021, the UK has led the vascular access catheters market in the European region, holding the majority of the market share of about 22.2%. Cancer is the one leading cause for the demand of vascular access devices in the UK, rising number of cancer cases has resulted in increased demand for central venous catheters and implantable ports for the treatment of chemotherapy. Increase in diseases is further expected to drive the market.
China held the majority share of about 43.3% of the East Asian vascular access catheters market by the end of 2021. The growing adoption rate of PTCS balloon catheters and CVC (central venous catheters) with minimally invasive procedures in removing the blockage of arteries and of such devices at reasonable costs, are major driving factors for the vascular access catheters market to grow in the future.
As per an article published in NCBI in 2019 as well as surveillance report published by China CDC in 2015, the mortality rate owing to cardiovascular disease in China is around 364.5 for every 1 lac population and that the overall CVD mortality rate has increased to 7.4%. Additionally, 47% of the total deaths in China is related to CVD which is closely related to the ageing population as well.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The PICC catheters has driven the product segment of vascular access catheters market by generating the revenue of over US$ 900.0 Mn as of 2021, and is expected to grow over a CAGR of 7.0% in the forecast years. The urge to reduce catheter related complications such as bloodstream infections and needle stick injuries, people are opting for catheter line insertion. Due to this the market of such relevant products is expected to boost in the coming years.
The non-antimicrobial catheters held the majority market share of over 75.0% of the total property segment market of global vascular access catheters market by the end of 2021. The property of non-antimicrobial catheters in preventing the bacterial growth over the surface of catheters and rise in prevalence of diseases resulting in more demands of vascular devices with non-antimicrobial property are the key drivers for the market expansion.
The double lumen catheters accounted for US$ 1.8 B by the end of 2021, and is expected grow over the CAGR of 6.1% during the forecast period, owing to the increase in prevalence of urology disorders such as kidney stones, urinary/bowel incontinence. Such conditions have raised the demands for catheters for their diagnosis. Wide availability of products and less invasive procedures are some major factors contributing to the growth vascular access catheters market.
Based on end user, the hospital segment accounted highest at US$ 1.7 Bn by the end of 2021. Increasing geriatric population and growing numbers of diseases and infections in the population has given rise to the adoption of catheters devices coupled with availability of highly skilled medical and healthcare professionals which has surged the patient’s preference toward hospitalization.
Advancements in biocompatibility, flexibility, and the adoption of novel materials are shaping the demand of such efficient and quality products in the vascular access catheters market.
Players in the vascular access catheters market are looking forward to expand their market and create strong hold in consumer base from long-term vascular access catheters (VACs). Manufacturers have benefitted from the growing understanding of the diagnosis of VAC-related infections. Technological advancements especially concerning to designs and materials have enabled healthcare workers to overcome complex VAC infection and complications. These factors are the prospects of new technologies in the vascular access catheters market.
Key pharma players proactively working in the vascular access catheters market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, B Braun Melsungen AG and others.
| Attribute | Details |
|---|---|
| Forecast Period | 2022-2032 |
| Historical Data Available for | 2012-2021 |
| Market Analysis | US$ Mn for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam , Philippines , Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA |
| Key Market Segments Covered | Product, application, end user, region |
| Key Companies Profiled | AngioDynamics; C.R. Bard; Teleflex Incorporated; Kimal; B. Braun Melsungen AG; Vygon (UK) Ltd.; Fresenius Kabi AG; Becton; Dickinson and Company; Argon Medical Devices, Inc.; Boston Scientific Corporation; Cook Medical Incorporated; Medical Components, Inc.; Medtronic PLC.; Terumo Medical Corporation; NIPRO Medical Corporation; Angiodynamics; Edwards Lifesciences Corporation |
| Pricing | Available upon Request |
The global vascular access catheters market is anticipated to achieve the valuation of about US$ 5.3 Bn by the end 2032.
The global vascular access catheters market is expected to grow over a CAGR of 7.2% during the forecast period.
The North American region achieved the highest revenue share of around 45% in 2021.
As of 2021, the non-antimicrobial catheters have led the global vascular access catheters with the revenue share of over 75%.
C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Incorporated, Medtronic PLC. are the major players in the market.
Increase in prevalence of chronic diseases, less invasive devices at reasonable costs, advancements in biocompatibility, flexibility, and the adoption of novel materials, innovations and research & development activities are the major driving factors for the global market.
The global market is estimated to reach the valuation of about US$ 3.0 Bn by the end of 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, by Region
4.2. Key promotional strategies by manufacturers
4.3. Regulatory Landscape
4.4. Value chain analysis
4.5. Product adoption analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Complexity of Healthcare Operations
5.2.3. Product Pricing
5.2.4. Product & Stock Availability
5.2.5. Rising Prevalence of Infections and Surgical Procedures
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. Revenue By Product
6.1.2. Revenue By Property
6.1.3. Revenue By Design
6.1.4. Revenue By End User
6.1.5. Revenue By Country
6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Design in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2012–2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012–2021 and Forecast 2022–2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2012–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2022–2032
8.3.1. Dialysis Catheters
8.3.1.1. Acute Hemodialysis Catheters
8.3.1.2. Chronic Hemodialysis Catheters
8.3.1.3. Peritoneal Dialysis Catheters
8.3.2. PICC Catheters
8.3.3. Implantable Port
8.3.4. CVC Catheters
8.3.4.1. Tunneled Catheters
8.3.4.2. Non-Tunneled Catheters
8.4. Market Attractiveness Analysis, by Product
9. Global Market Analysis 2012–2021 and Forecast 2022–2032, By Property
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Property, 2012–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Property, 2022–2032
9.3.1. Antimicrobial Catheters
9.3.2. Non-Antimicrobial Catheters
9.4. Market Attractiveness Analysis, by Property
10. Global Market Analysis 2012–2021 and Forecast 2022–2032, By Design
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Design, 2012–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Design, 2022–2032
10.3.1. Single Lumen
10.3.2. Double Lumen
10.3.3. Multiple Lumen
10.4. Market Attractiveness Analysis, by Design
11. Global Market Analysis 2012–2021 and Forecast 2022–2032, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Design, 2012–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Design, 2022–2032
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Dialysis Centers
11.3.4. Specialty Clinics and Others
11.4. Market Attractiveness Analysis, by End User
12. Global Market Analysis 2012–2021 and Forecast 2022–2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2012–2021
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis, by Region
13. North America Market Analysis 2012–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Property
13.3.4. By Design
13.3.5. By End User
13.4. By Country Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Property
13.4.4. By Design
13.4.5. By End User
13.5. By Country Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. U.S. Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
13.7.1.2.1. By Product
13.7.1.2.2. By Property
13.7.1.2.3. By Design
13.7.1.2.4. By End User
13.7.2. Canada Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
13.7.2.2.1. By Product
13.7.2.2.2. By Property
13.7.2.2.3. By Design
13.7.2.2.4. By End User
14. Latin America Market Analysis 2012–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Property
14.3.4. By Design
14.3.5. By End User
14.4. By Country By Country Market Attractiveness Analysis
14.4.1. By Product
14.4.2. By Property
14.4.3. By Design
14.4.4. By End User
14.5. By Country Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Mexico Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Property
14.7.1.2.3. By Design
14.7.1.2.4. By End User
14.7.2. Brazil Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Property
14.7.2.2.3. By Design
14.7.2.2.4. By End User
14.7.3. Argentina Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
14.7.3.2.1. By Product
14.7.3.2.2. By Property
14.7.3.2.3. By Design
14.7.3.2.4. By End User
15. Europe Market Analysis 2012–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Nordic Countries
15.3.1.9. Rest of Europe
15.3.2. By Product
15.3.3. By Property
15.3.4. By Design
15.3.5. By End User
15.4. By Country Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Property
15.4.3. By Design
15.4.4. By End User
15.5. By Country Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Germany Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Property
15.7.1.2.3. By Design
15.7.1.2.4. By End User
15.7.2. Italy Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Property
15.7.2.2.3. By Design
15.7.2.2.4. By End User
15.7.3. France Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Property
15.7.3.2.3. By Design
15.7.3.2.4. By End User
15.7.4. U.K. Market Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast, by Market Taxonomy
15.7.4.2.1. By Product
15.7.4.2.2. By Property
15.7.4.2.3. By Design
15.7.4.2.4. By End User
15.7.5. Spain Market Analysis
15.7.5.1. Introduction
15.7.5.2. Market Analysis and Forecast, by Market Taxonomy
15.7.5.2.1. By Product
15.7.5.2.2. By Property
15.7.5.2.3. By Design
15.7.5.2.4. By End User
15.7.6. BENELUX Market Analysis
15.7.6.1. Introduction
15.7.6.2. Market Analysis and Forecast, by Market Taxonomy
15.7.6.2.1. By Product
15.7.6.2.2. By Property
15.7.6.2.3. By Design
15.7.6.2.4. By End User
15.7.7. Russia Market Analysis
15.7.7.1. Introduction
15.7.7.2. Market Analysis and Forecast, by Market Taxonomy
15.7.7.2.1. By Product
15.7.7.2.2. By Property
15.7.7.2.3. By Design
15.7.7.2.4. By End User
15.7.8. Nordic Countries Market Analysis
15.7.8.1. Introduction
15.7.8.2. Market Analysis and Forecast, by Market Taxonomy
15.7.8.2.1. By Product
15.7.8.2.2. By Property
15.7.8.2.3. By Design
15.7.8.2.4. By End User
16. East Asia Market Analysis 2012–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Property
16.3.4. By Design
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Property
16.4.4. By Design
16.4.5. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. China Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Property
16.7.1.2.3. By Design
16.7.1.2.4. By End User
16.7.2. Japan Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Property
16.7.2.2.3. By Design
16.7.2.2.4. By End User
16.7.3. South Korea Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By Property
16.7.3.2.3. By Design
16.7.3.2.4. By End User
17. South Asia Market Analysis 2012–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Property
17.3.4. By Design
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Property
17.4.4. By Design
17.4.5. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Property
17.7.1.2.3. By Design
17.7.1.2.4. By End User
17.7.2. Indonesia Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Property
17.7.2.2.3. By Design
17.7.2.2.4. By End User
17.7.3. Malaysia Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Property
17.7.3.2.3. By Design
17.7.3.2.4. By End User
17.7.4. Thailand Market Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast, by Market Taxonomy
17.7.4.2.1. By Product
17.7.4.2.2. By Property
17.7.4.2.3. By Design
17.7.4.2.4. By End User
18. Oceania Market 2012-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Property
18.3.4. By Design
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Property
18.4.4. By Design
18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Australia Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Property
18.7.1.2.3. By Design
18.7.1.2.4. By End User
18.7.2. New Zealand Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By Property
18.7.2.2.3. By Design
18.7.2.2.4. By End User
19. Middle East and Africa (MEA) Market Analysis 2012–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2012–2021
19.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Market Taxonomy 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey ;
19.3.1.3. South Africa
19.3.1.4. Israel
19.3.1.5. North Africa
19.3.1.6. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Property
19.3.4. By Design
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Property
19.4.4. By Design
19.4.5. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. GCC Countries Market Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By Property
19.7.1.2.3. By Design
19.7.1.2.4. By End User
19.7.2. Turkey Market Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By Property
19.7.2.2.3. By Design
19.7.2.2.4. By End User
19.7.3. South Africa Market Analysis
19.7.3.1. Introduction
19.7.3.2. Market Analysis and Forecast, by Market Taxonomy
19.7.3.2.1. By Product
19.7.3.2.2. By Property
19.7.3.2.3. By Design
19.7.3.2.4. By End User
19.7.4. Israel Market Analysis
19.7.4.1. Introduction
19.7.4.2. Market Analysis and Forecast, by Market Taxonomy
19.7.4.2.1. By Product
19.7.4.2.2. By Property
19.7.4.2.3. By Design
19.7.4.2.4. By End User
19.7.5. North Africa Market
19.7.5.1. Introduction
19.7.5.2. Market Analysis and Forecast, by Market Taxonomy
19.7.5.2.1. By Product
19.7.5.2.2. By Property
19.7.5.2.3. By Design
19.7.5.2.4. By End User
20. Market Structure Analysis
20.1. Market Analysis, by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Becton, Dickinson and Company
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Strategy Overview
21.3.2. C.R. Bard
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Key Financials
21.3.2.5. SWOT Analysis
21.3.2.6. Strategy Overview
21.3.3. Teleflex Incorporated,
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Key Financials
21.3.3.5. SWOT Analysis
21.3.3.6. Strategy Overview
21.3.4. Kimal,
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Key Financials
21.3.4.5. SWOT Analysis
21.3.4.6. Strategy Overview
21.3.5. B. Braun Melsungen AG
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Key Financials
21.3.5.5. SWOT Analysis
21.3.5.6. Strategy Overview
21.3.6. Vygon (UK) Ltd.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Key Financials
21.3.6.5. SWOT Analysis
21.3.6.6. Strategy Overview
21.3.7. Fresenius Kabi AG
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Key Financials
21.3.7.5. SWOT Analysis
21.3.7.6. Strategy Overview
21.3.8. Argon Medical Devices, Inc.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Key Financials
21.3.8.5. SWOT Analysis
21.3.8.6. Strategy Overview
21.3.9. Boston Scientific Corporation
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Key Financials
21.3.9.5. SWOT Analysis
21.3.9.6. Strategy Overview
21.3.10. Cook Medical Incorporated
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Key Financials
21.3.10.5. SWOT Analysis
21.3.10.6. Strategy Overview
21.3.11. Medical Components, Inc.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Sales Footprint
21.3.11.4. Key Financials
21.3.11.5. SWOT Analysis
21.3.11.6. Strategy Overview
21.3.12. Medtronic PLC.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Sales Footprint
21.3.12.4. Key Financials
21.3.12.5. SWOT Analysis
21.3.12.6. Strategy Overview
21.3.13. Terumo Medical Corporation
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Sales Footprint
21.3.13.4. Key Financials
21.3.13.5. SWOT Analysis
21.3.13.6. Strategy Overview
21.3.14. NIPRO Medical Corporation
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Sales Footprint
21.3.14.4. Key Financials
21.3.14.5. SWOT Analysis
21.3.14.6. Strategy Overview
21.3.15. Angiodynamics
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Sales Footprint
21.3.15.4. Key Financials
21.3.15.5. SWOT Analysis
21.3.15.6. Strategy Overview
21.3.16. Edwards Lifesciences Corporation
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Sales Footprint
21.3.16.4. Key Financials
21.3.16.5. SWOT Analysis
21.3.16.6. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Vascular Access Catheters Market
